This statistic depicts the percentage of FDA-approved orphan drugs with and without additional non-orphan indications between 1983 and 2018. According to the data, in 2017, 14 percent of approved orphan drugs also had additional non-orphan indications.
Percentage of FDA-approved orphan drugs with additional non-orphan indications between 1983 and 2018
Orphan drugs with non-orphan indications
Orphan drugs with only orphan indications
-
-
-
-
-
-
-
-
-
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $59 / month
*
Access to this and all other statistics on 80,000 topics from
$708 / Year
Sources
Only available for customers
Survey by
Only available for customers
Published by
Only available for customers
Source link
https://www.statista.com
Release date
October 2018
Region
United States
Survey time period
as of September 2018
Supplementary notes
Total number of drugs 1983−2018 YTD=503; Counts distinct drugs approved with any orphan indication since the passage of the Orphan Drug Act.
Includes drug approvals through Aug 2018.
FDA approved orphan drugs with non-orphan indications 1983-2018
This statistic depicts the percentage of FDA-approved orphan drugs with and without additional non-orphan indications between 1983 and 2018. According to the data, in 2017, 14 percent of approved orphan drugs also had additional non-orphan indications.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
Statista Accounts:
Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
Instant access to 1m statistics
Download in XLS, PDF & PNG format
Detailed references
$59 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
Orphan drugs
All Information in one Presentation
Orphan drugs
56 page/s
English
pptx
Detailed references
Everything On "Orphan drugs" in One Document: Edited and Divided
into Handy Chapters. Including Detailed References.
Do you have any questions about our business solutions?
We provide you with detailed information about our Corporate Account.
Statista Accounts:
Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.
IQVIA. (October 24, 2018). Percentage of FDA-approved orphan drugs with additional non-orphan indications between 1983 and 2018 [Graph]. In Statista. Retrieved November 18, 2019, from https://www.statista.com/statistics/979229/approved-orphan-drugs-with-non-orphan-indications/
IQVIA. "Percentage of FDA-approved orphan drugs with additional non-orphan indications between 1983 and 2018." Chart. October 24, 2018. Statista. Accessed November 18, 2019. https://www.statista.com/statistics/979229/approved-orphan-drugs-with-non-orphan-indications/
IQVIA. (2018). Percentage of FDA-approved orphan drugs with additional non-orphan indications between 1983 and 2018. Statista. Statista Inc.. Accessed: November 18, 2019. https://www.statista.com/statistics/979229/approved-orphan-drugs-with-non-orphan-indications/
IQVIA. "Percentage of Fda-approved Orphan Drugs with Additional Non-orphan Indications between 1983 and 2018." Statista, Statista Inc., 24 Oct 2018, https://www.statista.com/statistics/979229/approved-orphan-drugs-with-non-orphan-indications/
IQVIA, Percentage of FDA-approved orphan drugs with additional non-orphan indications between 1983 and 2018 Statista, https://www.statista.com/statistics/979229/approved-orphan-drugs-with-non-orphan-indications/ (last visited November 18, 2019)
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.
